FCGBP Promotes Glioma Growth by Regulating JAK2 / STAT3 /c‐Myc Pathway
Cancer Medicine · 2026
DOI: 10.1002/cam4.71617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Jin Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Janus Kinase 2, STAT3 Transcription Factor, Glioma, Proto-Oncogene Proteins c-myc. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Natural Science Foundation of Hubei.
Abstract (Originalsprache)
Background
FCGBP has been implicated in the development of a variety of tumors, but its exact role in glioma progression remains unclear.
Methods
This study utilized qRT‐PCR, Western blotting (WB), immunohistochemistry (IHC), and other techniques to assess FCGBP expression in glioma tissues. Additionally, various functional experiments were conducted to investigate its role in glioma progression. Animal models were employed to further elucidate the function of FCGBP, with a particular focus on its impact on the Janus Kinase 2/Signal Transducer and Activator of Transcription 3 (JAK2/STAT3) signaling pathway.
Results
The research findings indicated that FCGBP is significantly overexpressed in glioma and is closely associated with higher tumor grades and unfavorable clinical outcomes. Functional assays demonstrated that FCGBP promotes glioma cell aggressiveness by activating the JAK2/STAT3 signaling pathway.
Conclusion
This study highlights the critical role of FCGBP in glioma aggression and poor prognosis, indicating that it could serve as a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
ORCID-Profile: Liang Liang Shi
Förderung
- The Natural Science Foundation of Hubei
Zitieren
APA
Zheng, J., Rao, Y. X., Zheng, H., & Shi, L. L. (2026). FCGBP Promotes Glioma Growth by Regulating JAK2 / STAT3 /c‐Myc Pathway. Cancer Medicine. https://doi.org/10.1002/cam4.71617
Vancouver
Zheng J, Rao YX, Zheng H, Shi LL. FCGBP Promotes Glioma Growth by Regulating JAK2 / STAT3 /c‐Myc Pathway. Cancer Medicine. 2026. doi:10.1002/cam4.71617
BibTeX
@article{Zheng2026,
author = {Zheng, Jin and Rao, Yu Xin and Zheng, Hui and Shi, Liang Liang},
title = {FCGBP Promotes Glioma Growth by Regulating JAK2 / STAT3 /c‐Myc Pathway},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.71617}
}
EUVIMED